American Journal of Cancer Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1237156, encodeId=3d71123e15673, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：尼玛，等了快4个月了，还在under review，别搞我呀<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Aug 07 21:35:35 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957549, encodeId=116295e549d0, content=这个杂志接收后，大概多久交钱，收到清样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af335141421, createdName=haha, createdTime=Fri Apr 16 10:53:51 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903863, encodeId=467d90386375, content=今天收到催稿信的回复了，review received是指查重过了，并不能说明任何问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/28/652045131576bd5eaa11d7dd05d7f41e.jpg, createdBy=f8175173713, createdName=156580, createdTime=Tue Dec 01 14:11:05 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=921223, encodeId=fd9092122323, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：JBC近两年有100篇论文western造假都没上中科院的警告名单，再加上最近的cxt事件，可见中科院现在已经逐渐失去公信力，这样也好，以后编辑的审稿会越来越严格，会越来越难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51505457203, createdName=ms7000000176832132, createdTime=Fri Jan 29 22:39:09 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907088, encodeId=4d1290e08864, content=请问各位这个杂志如果文章接收了也proof了大概多久能online？？我的已经proof了一个月了也还没有扣款, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4702030301, createdName=3791, createdTime=Fri Dec 11 16:01:14 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215379, encodeId=18b212153e923, content=审稿速度:24.0 经验分享：3月13号投的，一投就是under review，邮箱也当天收到了manuscript received的邮件，到现在一直都是under review，请问什么情况呀，每天看一次，都没有试过什么reviews received和别的状态都没有。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Apr 28 17:18:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896605, encodeId=ca0f896605cf, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿后 under review 7天，状态变为reject，但是，review comments让补充原始图片再次投稿，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Tue Nov 03 14:36:05 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914754, encodeId=c391914e545c, content=分享一下，投稿后5天变成review received，1个多月了没进展。然后写邮件问了杂志社了，对方回复说，投稿后会先查重，查重结果是审稿意见之一，所以系统显示review received。还在同行评审中………要我耐心等待。所以情况一样的，大家还是一起焦虑等待吧🤪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a36a2145509, createdName=biubiuyaya, createdTime=Fri Jan 08 23:17:26 CST 2021, time=2021-01-08, status=1, ipAttribution=)]

2022-08-07 ms2000001076054986

审稿速度:6.0 | 投稿命中率:5.0
经验分享：尼玛，等了快4个月了，还在under review，别搞我呀#心血管#

130 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1237156, encodeId=3d71123e15673, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：尼玛，等了快4个月了，还在under review，别搞我呀<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Aug 07 21:35:35 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957549, encodeId=116295e549d0, content=这个杂志接收后，大概多久交钱，收到清样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af335141421, createdName=haha, createdTime=Fri Apr 16 10:53:51 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903863, encodeId=467d90386375, content=今天收到催稿信的回复了，review received是指查重过了，并不能说明任何问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/28/652045131576bd5eaa11d7dd05d7f41e.jpg, createdBy=f8175173713, createdName=156580, createdTime=Tue Dec 01 14:11:05 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=921223, encodeId=fd9092122323, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：JBC近两年有100篇论文western造假都没上中科院的警告名单，再加上最近的cxt事件，可见中科院现在已经逐渐失去公信力，这样也好，以后编辑的审稿会越来越严格，会越来越难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51505457203, createdName=ms7000000176832132, createdTime=Fri Jan 29 22:39:09 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907088, encodeId=4d1290e08864, content=请问各位这个杂志如果文章接收了也proof了大概多久能online？？我的已经proof了一个月了也还没有扣款, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4702030301, createdName=3791, createdTime=Fri Dec 11 16:01:14 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215379, encodeId=18b212153e923, content=审稿速度:24.0 经验分享：3月13号投的，一投就是under review，邮箱也当天收到了manuscript received的邮件，到现在一直都是under review，请问什么情况呀，每天看一次，都没有试过什么reviews received和别的状态都没有。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Apr 28 17:18:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896605, encodeId=ca0f896605cf, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿后 under review 7天，状态变为reject，但是，review comments让补充原始图片再次投稿，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Tue Nov 03 14:36:05 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914754, encodeId=c391914e545c, content=分享一下，投稿后5天变成review received，1个多月了没进展。然后写邮件问了杂志社了，对方回复说，投稿后会先查重，查重结果是审稿意见之一，所以系统显示review received。还在同行评审中………要我耐心等待。所以情况一样的，大家还是一起焦虑等待吧🤪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a36a2145509, createdName=biubiuyaya, createdTime=Fri Jan 08 23:17:26 CST 2021, time=2021-01-08, status=1, ipAttribution=)]

2021-04-16 haha

这个杂志接收后，大概多久交钱，收到清样啊

110 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1237156, encodeId=3d71123e15673, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：尼玛，等了快4个月了，还在under review，别搞我呀<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Aug 07 21:35:35 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957549, encodeId=116295e549d0, content=这个杂志接收后，大概多久交钱，收到清样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af335141421, createdName=haha, createdTime=Fri Apr 16 10:53:51 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903863, encodeId=467d90386375, content=今天收到催稿信的回复了，review received是指查重过了，并不能说明任何问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/28/652045131576bd5eaa11d7dd05d7f41e.jpg, createdBy=f8175173713, createdName=156580, createdTime=Tue Dec 01 14:11:05 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=921223, encodeId=fd9092122323, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：JBC近两年有100篇论文western造假都没上中科院的警告名单，再加上最近的cxt事件，可见中科院现在已经逐渐失去公信力，这样也好，以后编辑的审稿会越来越严格，会越来越难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51505457203, createdName=ms7000000176832132, createdTime=Fri Jan 29 22:39:09 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907088, encodeId=4d1290e08864, content=请问各位这个杂志如果文章接收了也proof了大概多久能online？？我的已经proof了一个月了也还没有扣款, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4702030301, createdName=3791, createdTime=Fri Dec 11 16:01:14 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215379, encodeId=18b212153e923, content=审稿速度:24.0 经验分享：3月13号投的，一投就是under review，邮箱也当天收到了manuscript received的邮件，到现在一直都是under review，请问什么情况呀，每天看一次，都没有试过什么reviews received和别的状态都没有。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Apr 28 17:18:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896605, encodeId=ca0f896605cf, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿后 under review 7天，状态变为reject，但是，review comments让补充原始图片再次投稿，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Tue Nov 03 14:36:05 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914754, encodeId=c391914e545c, content=分享一下，投稿后5天变成review received，1个多月了没进展。然后写邮件问了杂志社了，对方回复说，投稿后会先查重，查重结果是审稿意见之一，所以系统显示review received。还在同行评审中………要我耐心等待。所以情况一样的，大家还是一起焦虑等待吧🤪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a36a2145509, createdName=biubiuyaya, createdTime=Fri Jan 08 23:17:26 CST 2021, time=2021-01-08, status=1, ipAttribution=)]

2020-12-01 156580

今天收到催稿信的回复了，review received是指查重过了，并不能说明任何问题。

91 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1237156, encodeId=3d71123e15673, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：尼玛，等了快4个月了，还在under review，别搞我呀<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Aug 07 21:35:35 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957549, encodeId=116295e549d0, content=这个杂志接收后，大概多久交钱，收到清样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af335141421, createdName=haha, createdTime=Fri Apr 16 10:53:51 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903863, encodeId=467d90386375, content=今天收到催稿信的回复了，review received是指查重过了，并不能说明任何问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/28/652045131576bd5eaa11d7dd05d7f41e.jpg, createdBy=f8175173713, createdName=156580, createdTime=Tue Dec 01 14:11:05 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=921223, encodeId=fd9092122323, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：JBC近两年有100篇论文western造假都没上中科院的警告名单，再加上最近的cxt事件，可见中科院现在已经逐渐失去公信力，这样也好，以后编辑的审稿会越来越严格，会越来越难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51505457203, createdName=ms7000000176832132, createdTime=Fri Jan 29 22:39:09 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907088, encodeId=4d1290e08864, content=请问各位这个杂志如果文章接收了也proof了大概多久能online？？我的已经proof了一个月了也还没有扣款, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4702030301, createdName=3791, createdTime=Fri Dec 11 16:01:14 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215379, encodeId=18b212153e923, content=审稿速度:24.0 经验分享：3月13号投的，一投就是under review，邮箱也当天收到了manuscript received的邮件，到现在一直都是under review，请问什么情况呀，每天看一次，都没有试过什么reviews received和别的状态都没有。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Apr 28 17:18:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896605, encodeId=ca0f896605cf, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿后 under review 7天，状态变为reject，但是，review comments让补充原始图片再次投稿，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Tue Nov 03 14:36:05 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914754, encodeId=c391914e545c, content=分享一下，投稿后5天变成review received，1个多月了没进展。然后写邮件问了杂志社了，对方回复说，投稿后会先查重，查重结果是审稿意见之一，所以系统显示review received。还在同行评审中………要我耐心等待。所以情况一样的，大家还是一起焦虑等待吧🤪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a36a2145509, createdName=biubiuyaya, createdTime=Fri Jan 08 23:17:26 CST 2021, time=2021-01-08, status=1, ipAttribution=)]

2023-08-05 shademei 来自河北省

偏重的研究方向：肿瘤学
经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的

0 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1237156, encodeId=3d71123e15673, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：尼玛，等了快4个月了，还在under review，别搞我呀<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Aug 07 21:35:35 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957549, encodeId=116295e549d0, content=这个杂志接收后，大概多久交钱，收到清样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af335141421, createdName=haha, createdTime=Fri Apr 16 10:53:51 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903863, encodeId=467d90386375, content=今天收到催稿信的回复了，review received是指查重过了，并不能说明任何问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/28/652045131576bd5eaa11d7dd05d7f41e.jpg, createdBy=f8175173713, createdName=156580, createdTime=Tue Dec 01 14:11:05 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=921223, encodeId=fd9092122323, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：JBC近两年有100篇论文western造假都没上中科院的警告名单，再加上最近的cxt事件，可见中科院现在已经逐渐失去公信力，这样也好，以后编辑的审稿会越来越严格，会越来越难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51505457203, createdName=ms7000000176832132, createdTime=Fri Jan 29 22:39:09 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907088, encodeId=4d1290e08864, content=请问各位这个杂志如果文章接收了也proof了大概多久能online？？我的已经proof了一个月了也还没有扣款, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4702030301, createdName=3791, createdTime=Fri Dec 11 16:01:14 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215379, encodeId=18b212153e923, content=审稿速度:24.0 经验分享：3月13号投的，一投就是under review，邮箱也当天收到了manuscript received的邮件，到现在一直都是under review，请问什么情况呀，每天看一次，都没有试过什么reviews received和别的状态都没有。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Apr 28 17:18:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896605, encodeId=ca0f896605cf, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿后 under review 7天，状态变为reject，但是，review comments让补充原始图片再次投稿，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Tue Nov 03 14:36:05 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914754, encodeId=c391914e545c, content=分享一下，投稿后5天变成review received，1个多月了没进展。然后写邮件问了杂志社了，对方回复说，投稿后会先查重，查重结果是审稿意见之一，所以系统显示review received。还在同行评审中………要我耐心等待。所以情况一样的，大家还是一起焦虑等待吧🤪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a36a2145509, createdName=biubiuyaya, createdTime=Fri Jan 08 23:17:26 CST 2021, time=2021-01-08, status=1, ipAttribution=)]

2021-01-29 ms7000000176832132

审稿速度:2.0 | 投稿命中率:5.0
经验分享：JBC近两年有100篇论文western造假都没上中科院的警告名单，再加上最近的cxt事件，可见中科院现在已经逐渐失去公信力，这样也好，以后编辑的审稿会越来越严格，会越来越难投

243 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1237156, encodeId=3d71123e15673, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：尼玛，等了快4个月了，还在under review，别搞我呀<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Aug 07 21:35:35 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957549, encodeId=116295e549d0, content=这个杂志接收后，大概多久交钱，收到清样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af335141421, createdName=haha, createdTime=Fri Apr 16 10:53:51 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903863, encodeId=467d90386375, content=今天收到催稿信的回复了，review received是指查重过了，并不能说明任何问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/28/652045131576bd5eaa11d7dd05d7f41e.jpg, createdBy=f8175173713, createdName=156580, createdTime=Tue Dec 01 14:11:05 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=921223, encodeId=fd9092122323, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：JBC近两年有100篇论文western造假都没上中科院的警告名单，再加上最近的cxt事件，可见中科院现在已经逐渐失去公信力，这样也好，以后编辑的审稿会越来越严格，会越来越难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51505457203, createdName=ms7000000176832132, createdTime=Fri Jan 29 22:39:09 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907088, encodeId=4d1290e08864, content=请问各位这个杂志如果文章接收了也proof了大概多久能online？？我的已经proof了一个月了也还没有扣款, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4702030301, createdName=3791, createdTime=Fri Dec 11 16:01:14 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215379, encodeId=18b212153e923, content=审稿速度:24.0 经验分享：3月13号投的，一投就是under review，邮箱也当天收到了manuscript received的邮件，到现在一直都是under review，请问什么情况呀，每天看一次，都没有试过什么reviews received和别的状态都没有。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Apr 28 17:18:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896605, encodeId=ca0f896605cf, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿后 under review 7天，状态变为reject，但是，review comments让补充原始图片再次投稿，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Tue Nov 03 14:36:05 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914754, encodeId=c391914e545c, content=分享一下，投稿后5天变成review received，1个多月了没进展。然后写邮件问了杂志社了，对方回复说，投稿后会先查重，查重结果是审稿意见之一，所以系统显示review received。还在同行评审中………要我耐心等待。所以情况一样的，大家还是一起焦虑等待吧🤪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a36a2145509, createdName=biubiuyaya, createdTime=Fri Jan 08 23:17:26 CST 2021, time=2021-01-08, status=1, ipAttribution=)]

2020-12-11 3791

请问各位这个杂志如果文章接收了也proof了大概多久能online？？我的已经proof了一个月了也还没有扣款

119 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1237156, encodeId=3d71123e15673, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：尼玛，等了快4个月了，还在under review，别搞我呀<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Aug 07 21:35:35 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957549, encodeId=116295e549d0, content=这个杂志接收后，大概多久交钱，收到清样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af335141421, createdName=haha, createdTime=Fri Apr 16 10:53:51 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903863, encodeId=467d90386375, content=今天收到催稿信的回复了，review received是指查重过了，并不能说明任何问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/28/652045131576bd5eaa11d7dd05d7f41e.jpg, createdBy=f8175173713, createdName=156580, createdTime=Tue Dec 01 14:11:05 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=921223, encodeId=fd9092122323, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：JBC近两年有100篇论文western造假都没上中科院的警告名单，再加上最近的cxt事件，可见中科院现在已经逐渐失去公信力，这样也好，以后编辑的审稿会越来越严格，会越来越难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51505457203, createdName=ms7000000176832132, createdTime=Fri Jan 29 22:39:09 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907088, encodeId=4d1290e08864, content=请问各位这个杂志如果文章接收了也proof了大概多久能online？？我的已经proof了一个月了也还没有扣款, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4702030301, createdName=3791, createdTime=Fri Dec 11 16:01:14 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215379, encodeId=18b212153e923, content=审稿速度:24.0 经验分享：3月13号投的，一投就是under review，邮箱也当天收到了manuscript received的邮件，到现在一直都是under review，请问什么情况呀，每天看一次，都没有试过什么reviews received和别的状态都没有。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Apr 28 17:18:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896605, encodeId=ca0f896605cf, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿后 under review 7天，状态变为reject，但是，review comments让补充原始图片再次投稿，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Tue Nov 03 14:36:05 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914754, encodeId=c391914e545c, content=分享一下，投稿后5天变成review received，1个多月了没进展。然后写邮件问了杂志社了，对方回复说，投稿后会先查重，查重结果是审稿意见之一，所以系统显示review received。还在同行评审中………要我耐心等待。所以情况一样的，大家还是一起焦虑等待吧🤪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a36a2145509, createdName=biubiuyaya, createdTime=Fri Jan 08 23:17:26 CST 2021, time=2021-01-08, status=1, ipAttribution=)]

2022-04-28 12463b17m04(暂无昵称)

审稿速度:24.0
经验分享：3月13号投的，一投就是under review，邮箱也当天收到了manuscript received的邮件，到现在一直都是under review，请问什么情况呀，每天看一次，都没有试过什么reviews received和别的状态都没有。。。。。

56 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1237156, encodeId=3d71123e15673, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：尼玛，等了快4个月了，还在under review，别搞我呀<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Aug 07 21:35:35 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957549, encodeId=116295e549d0, content=这个杂志接收后，大概多久交钱，收到清样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af335141421, createdName=haha, createdTime=Fri Apr 16 10:53:51 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903863, encodeId=467d90386375, content=今天收到催稿信的回复了，review received是指查重过了，并不能说明任何问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/28/652045131576bd5eaa11d7dd05d7f41e.jpg, createdBy=f8175173713, createdName=156580, createdTime=Tue Dec 01 14:11:05 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=921223, encodeId=fd9092122323, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：JBC近两年有100篇论文western造假都没上中科院的警告名单，再加上最近的cxt事件，可见中科院现在已经逐渐失去公信力，这样也好，以后编辑的审稿会越来越严格，会越来越难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51505457203, createdName=ms7000000176832132, createdTime=Fri Jan 29 22:39:09 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907088, encodeId=4d1290e08864, content=请问各位这个杂志如果文章接收了也proof了大概多久能online？？我的已经proof了一个月了也还没有扣款, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4702030301, createdName=3791, createdTime=Fri Dec 11 16:01:14 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215379, encodeId=18b212153e923, content=审稿速度:24.0 经验分享：3月13号投的，一投就是under review，邮箱也当天收到了manuscript received的邮件，到现在一直都是under review，请问什么情况呀，每天看一次，都没有试过什么reviews received和别的状态都没有。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Apr 28 17:18:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896605, encodeId=ca0f896605cf, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿后 under review 7天，状态变为reject，但是，review comments让补充原始图片再次投稿，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Tue Nov 03 14:36:05 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914754, encodeId=c391914e545c, content=分享一下，投稿后5天变成review received，1个多月了没进展。然后写邮件问了杂志社了，对方回复说，投稿后会先查重，查重结果是审稿意见之一，所以系统显示review received。还在同行评审中………要我耐心等待。所以情况一样的，大家还是一起焦虑等待吧🤪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a36a2145509, createdName=biubiuyaya, createdTime=Fri Jan 08 23:17:26 CST 2021, time=2021-01-08, status=1, ipAttribution=)]

2020-11-03 jeinne

审稿速度:1.0 | 投稿命中率:50.0
经验分享：投稿后 under review 7天，状态变为reject，但是，review comments让补充原始图片再次投稿，什么情况？

122 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1237156, encodeId=3d71123e15673, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：尼玛，等了快4个月了，还在under review，别搞我呀<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Aug 07 21:35:35 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957549, encodeId=116295e549d0, content=这个杂志接收后，大概多久交钱，收到清样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af335141421, createdName=haha, createdTime=Fri Apr 16 10:53:51 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903863, encodeId=467d90386375, content=今天收到催稿信的回复了，review received是指查重过了，并不能说明任何问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/28/652045131576bd5eaa11d7dd05d7f41e.jpg, createdBy=f8175173713, createdName=156580, createdTime=Tue Dec 01 14:11:05 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=921223, encodeId=fd9092122323, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：JBC近两年有100篇论文western造假都没上中科院的警告名单，再加上最近的cxt事件，可见中科院现在已经逐渐失去公信力，这样也好，以后编辑的审稿会越来越严格，会越来越难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51505457203, createdName=ms7000000176832132, createdTime=Fri Jan 29 22:39:09 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907088, encodeId=4d1290e08864, content=请问各位这个杂志如果文章接收了也proof了大概多久能online？？我的已经proof了一个月了也还没有扣款, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4702030301, createdName=3791, createdTime=Fri Dec 11 16:01:14 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215379, encodeId=18b212153e923, content=审稿速度:24.0 经验分享：3月13号投的，一投就是under review，邮箱也当天收到了manuscript received的邮件，到现在一直都是under review，请问什么情况呀，每天看一次，都没有试过什么reviews received和别的状态都没有。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Apr 28 17:18:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896605, encodeId=ca0f896605cf, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿后 under review 7天，状态变为reject，但是，review comments让补充原始图片再次投稿，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Tue Nov 03 14:36:05 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914754, encodeId=c391914e545c, content=分享一下，投稿后5天变成review received，1个多月了没进展。然后写邮件问了杂志社了，对方回复说，投稿后会先查重，查重结果是审稿意见之一，所以系统显示review received。还在同行评审中………要我耐心等待。所以情况一样的，大家还是一起焦虑等待吧🤪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a36a2145509, createdName=biubiuyaya, createdTime=Fri Jan 08 23:17:26 CST 2021, time=2021-01-08, status=1, ipAttribution=)]

2021-11-13 ms3000001370941770

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊

67 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1237156, encodeId=3d71123e15673, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：尼玛，等了快4个月了，还在under review，别搞我呀<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Sun Aug 07 21:35:35 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957549, encodeId=116295e549d0, content=这个杂志接收后，大概多久交钱，收到清样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af335141421, createdName=haha, createdTime=Fri Apr 16 10:53:51 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903863, encodeId=467d90386375, content=今天收到催稿信的回复了，review received是指查重过了，并不能说明任何问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/28/652045131576bd5eaa11d7dd05d7f41e.jpg, createdBy=f8175173713, createdName=156580, createdTime=Tue Dec 01 14:11:05 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=921223, encodeId=fd9092122323, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：JBC近两年有100篇论文western造假都没上中科院的警告名单，再加上最近的cxt事件，可见中科院现在已经逐渐失去公信力，这样也好，以后编辑的审稿会越来越严格，会越来越难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51505457203, createdName=ms7000000176832132, createdTime=Fri Jan 29 22:39:09 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907088, encodeId=4d1290e08864, content=请问各位这个杂志如果文章接收了也proof了大概多久能online？？我的已经proof了一个月了也还没有扣款, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4702030301, createdName=3791, createdTime=Fri Dec 11 16:01:14 CST 2020, time=2020-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215379, encodeId=18b212153e923, content=审稿速度:24.0 经验分享：3月13号投的，一投就是under review，邮箱也当天收到了manuscript received的邮件，到现在一直都是under review，请问什么情况呀，每天看一次，都没有试过什么reviews received和别的状态都没有。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Apr 28 17:18:36 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896605, encodeId=ca0f896605cf, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿后 under review 7天，状态变为reject，但是，review comments让补充原始图片再次投稿，什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Tue Nov 03 14:36:05 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914754, encodeId=c391914e545c, content=分享一下，投稿后5天变成review received，1个多月了没进展。然后写邮件问了杂志社了，对方回复说，投稿后会先查重，查重结果是审稿意见之一，所以系统显示review received。还在同行评审中………要我耐心等待。所以情况一样的，大家还是一起焦虑等待吧🤪, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a36a2145509, createdName=biubiuyaya, createdTime=Fri Jan 08 23:17:26 CST 2021, time=2021-01-08, status=1, ipAttribution=)]

2021-01-08 biubiuyaya

分享一下，投稿后5天变成review received，1个多月了没进展。然后写邮件问了杂志社了，对方回复说，投稿后会先查重，查重结果是审稿意见之一，所以系统显示review received。还在同行评审中………要我耐心等待。所以情况一样的，大家还是一起焦虑等待吧🤪

85 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务